FGF2-adsorbed macroporous hydroxyapatite bone granules stimulate in vitro osteoblastic gene expression and...

Area of Science:

• Biomaterials Engineering
• Regenerative Medicine
• Cell Biology

Background:

• Hydroxyapatite (HA) is a key component of bone, making it a promising material for bone regeneration.
• Basic fibroblast growth factor (FGF2) is known to stimulate cell proliferation and differentiation.
• Developing effective scaffolds for bone regeneration remains a significant challenge in orthopedic research.

Purpose of the Study:

• To investigate the in vitro scaffolding capabilities of FGF2-adsorbed hydroxyapatite bone granules.
• To evaluate the impact of FGF2 treatment on cell population and osteogenic differentiation on porous HA granules.
• To assess the potential of these modified granules for bone regeneration.

Main Methods:

• Production of macroporous hydroxyapatite bone granules.
• Adsorption of basic fibroblast growth factor (FGF2) onto the HA granules.
• In vitro culture of MC3T3-E1 cells on both FGF2-treated and untreated HA granules.
• Assessment of cell adhesion, proliferation, gene expression (collagen type I, alkaline phosphatase, osteocalcin), and alkaline phosphatase production.

Main Results:

• FGF2-adsorbed HA granules supported excellent MC3T3-E1 cell adhesion and proliferation.
• While overall cell growth was similar to untreated granules, FGF2 treatment significantly upregulated bone-related gene expression (collagen type I, alkaline phosphatase, osteocalcin) early on.
• Alkaline phosphatase production was notably enhanced with prolonged culturing on FGF2-adsorbed granules.

Conclusions:

• FGF2 treatment effectively enhances osteogenic development on hydroxyapatite bone granules.
• FGF2-adsorbed hydroxyapatite granules demonstrate significant potential as a biomaterial for bone regeneration.
• These findings suggest a promising therapeutic strategy for enhancing bone repair and regeneration.